Finance

Lists
COR:NYSE
Cencora Inc
323,85 USD
+0,78%
(+2,50) 1D
323,85 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COR...
Open
319,50 USD
High
325,82 USD
Low
318,79 USD
Mkt. cap
14,31 млд
Avg. vol.
1,26 млн
Volume
781,94 миң
52-wk high
377,54 USD
52-wk low
244,82 USD
Beta
0,58
Shares outstanding
190,83 млн
No. of employees
49 миң
Open
319,50 USD
High
325,82 USD
Low
318,79 USD
Mkt. cap
14,31 млд
Avg. vol.
1,26 млн
Volume
781,94 миң
52-wk high
377,54 USD
52-wk low
244,82 USD
Beta
0,58
Shares outstanding
190,83 млн
No. of employees
49 миң
News stories
From web sources and news partners
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49 миң
Founded1871
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 13 analysts giving stock ratings to COR in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for COR in the last 3 months.
Highest
Current 323,85 USD
430,00 USD (+32,78%)
Average
370,75 USD (+14,48%)
Lowest
330,00 USD (+1,90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
388,00 USD
+19,8%
10/07/2026
Ryan Halsted
RBC Capital
Hold
Maintained
330,00 USD
+1,9%
10/06/2026
Glen Santangelo
Barclays
Buy
Reiterated
350,00 USD
+8,1%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
350,00 USD
+8,1%
08/13/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
330,00 USD
+1,9%
08/12/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
390,00 USD
+20,4%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
395,00 USD
+22%
08/11/2026
Charles Rhyee
TD Cowen
Buy
Maintained
400,00 USD
+23,5%
08/09/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
346,00 USD
+6,8%
08/07/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
370,00 USD
+14,3%
08/06/2026
Kevin Caliendo
UBS
Buy
Maintained
430,00 USD
+32,8%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
370,00 USD
+14,3%
08/06/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
08/05/2026
Max Smock
William Blair
Hold
Maintained
-
-
05/22/2026
David Toung
Argus Research
Buy
Reiterated
400,00 USD
+23,5%
03/17/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q3 2026
4,48 USD / 4,35 USD
+3,04%beat
Revenue / Est. (USD)
84,75 млд / 84,15 млд
+0,72%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
83,73 млд
85,93 млд
78,36 млд
84,75 млд
Cost of goods sold
80,78 млд
82,87 млд
74,78 млд
81,15 млд
Cost of revenue
80,78 млд
82,87 млд
74,78 млд
81,15 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75 млд
1,80 млд
1,98 млд
2,13 млд
Operating expense
2,00 млд
2,06 млд
2,23 млд
2,40 млд
Total operating expenses
82,78 млд
84,93 млд
77,01 млд
83,56 млд
Operating income
944,58 млн
1,00 млд
1,34 млд
1,20 млд
Other non operating income
-49,91 млн
10,10 млн
-173,00 миң
16,88 млн
EBT including unusual items
-187,04 млн
708,64 млн
2,09 млд
996,39 млн
EBT excluding unusual items
795,23 млн
941,56 млн
1,20 млд
1,08 млд
Income tax expense
146,03 млн
142,51 млн
459,04 млн
219,73 млн
Effective tax rate
-78,07%
20,11%
21,98%
22,05%
Other operating expenses
-4,00 млн
362,00 миң
595,00 миң
881,00 миң
Net income
-339,70 млн
559,65 млн
1,64 млд
763,52 млн
Net profit margin
-0,41%
0,65%
2,09%
0,90%
Earnings per share
3,84
4,08
4,75
4,48
Interest and investment income
31,52 млн
20,95 млн
13,88 млн
13,82 млн
Interest expense
-109,36 млн
-93,36 млн
-154,34 млн
-154,52 млн
Net interest expenses
-77,83 млн
-72,41 млн
-140,46 млн
-140,70 млн
Depreciation and amortization charges
131,49 млн
134,29 млн
132,14 млн
150,96 млн
EBITDA
1,21 млд
1,27 млд
1,60 млд
1,47 млд
Gain or loss from assets sale
-
-35,82 млн
-234,00 миң
-15,96 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору